{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Study+Product&page=11", "query": { "intervention": "Control Study Product", "page": 11 }, "page_size": 10 }, "pagination": { "page": 11, "page_size": 10, "total_count": 4228, "total_pages": 423, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Study+Product&page=12&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Study+Product&page=10&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-20T20:45:18.613Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04010305", "title": "Sub-Lingual Dexmedetomidine in Agitation Associated With Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Agitation", "Schizophrenia" ], "interventions": [ { "name": "Sublingual film containing BXCL501 (Dexmedetomidine)", "type": "DRUG" }, { "name": "Placebo film", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "BioXcel Therapeutics Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 135, "start_date": "2019-05-22", "completion_date": "2019-07-31", "has_results": false, "last_update_posted_date": "2026-08-11", "last_synced_at": "2026-10-20T20:45:18.613Z", "location_count": 12, "location_summary": "Little Rock, Arkansas • Cerritos, California • Lemon Grove, California + 9 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Cerritos", "state": "California" }, { "city": "Lemon Grove", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Orange", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04010305" }, { "nct_id": "NCT00635531", "title": "A Study to Evaluate the Use of Extended Release Alprazolam in the Treatment of Adolescents With Panic Disorder", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Panic Disorder" ], "interventions": [ { "name": "placebo", "type": "OTHER" }, { "name": "alprazolam XR", "type": "DRUG" } ], "intervention_types": [ "OTHER", "DRUG" ], "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "13 Years to 17 Years" }, "enrollment_count": 16, "start_date": "2004-04", "completion_date": "2004-09", "has_results": false, "last_update_posted_date": "2021-01-28", "last_synced_at": "2026-10-20T20:45:18.613Z", "location_count": 18, "location_summary": "Hialeah, Florida • Jacksonville, Florida • North Miami, Florida + 15 more", "locations": [ { "city": "Hialeah", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "North Miami", "state": "Florida" }, { "city": "Boise", "state": "Idaho" }, { "city": "Terre Haute", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT00635531" }, { "nct_id": "NCT04420195", "title": "Envarsus XR in Lung Transplant", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Lung Transplant" ], "interventions": [ { "name": "Extended-Release Tacrolimus", "type": "DRUG" }, { "name": "Immediate-Release Tacrolimus", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "NYU Langone Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 41, "start_date": "2020-10-23", "completion_date": "2022-11-30", "has_results": true, "last_update_posted_date": "2024-01-22", "last_synced_at": "2026-10-20T20:45:18.613Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04420195" }, { "nct_id": "NCT00000912", "title": "A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "HIV Infections" ], "interventions": [ { "name": "Indinavir sulfate", "type": "DRUG" }, { "name": "Abacavir sulfate", "type": "DRUG" }, { "name": "Amprenavir", "type": "DRUG" }, { "name": "Nelfinavir mesylate", "type": "DRUG" }, { "name": "Efavirenz", "type": "DRUG" }, { "name": "Levocarnitine", "type": "DRUG" }, { "name": "Adefovir dipivoxil", "type": "DRUG" }, { "name": "Saquinavir", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": null, "sex": "ALL", "summary": "13 Years and older" }, "enrollment_count": 475, "start_date": null, "completion_date": "2000-05", "has_results": false, "last_update_posted_date": "2021-10-29", "last_synced_at": "2026-10-20T20:45:18.613Z", "location_count": 44, "location_summary": "Los Angeles, California • Menlo Park, California • San Diego, California + 27 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Menlo Park", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00000912" }, { "nct_id": "NCT06428630", "title": "Systemic Absorption of Dexamethasone Oral Rinse in Patients With Oral Lichen Planus", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Oral Lichen Planus", "Oral Lichenoid Reaction" ], "interventions": [ { "name": "dexamethasone oral rinse", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Tufts University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2025-05-01", "completion_date": "2027-09-01", "has_results": false, "last_update_posted_date": "2025-05-14", "last_synced_at": "2026-10-20T20:45:18.613Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT06428630" }, { "nct_id": "NCT06671054", "title": "A Dose Response Study to Evaluate the Efficacy and Safety of Oral AP1189 Administered in Disease-Modifying Anti-Rheumatic Drug (DMARD) naïve Participants Participants With Early Rheumatoid Arthritis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rheumatoid Arthritis (RA)" ], "interventions": [ { "name": "AP1189, 40 mg", "type": "DRUG" }, { "name": "AP1189, 70 mg", "type": "DRUG" }, { "name": "AP1189, 100 mg", "type": "DRUG" }, { "name": "AP1189 matching placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "SynAct Pharma Aps", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 240, "start_date": "2024-10-01", "completion_date": "2025-12", "has_results": false, "last_update_posted_date": "2025-10-06", "last_synced_at": "2026-10-20T20:45:18.613Z", "location_count": 3, "location_summary": "Cutler Bay, Florida • Miami, Florida • Duncansville, Pennsylvania", "locations": [ { "city": "Cutler Bay", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Duncansville", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT06671054" }, { "nct_id": "NCT03889886", "title": "Study to Evaluate the Safety and Efficacy of SDP-4 in Subjects With Dry Eye Disease (DED)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Dry Eye" ], "interventions": [ { "name": "SDP-4 Ophthalmic Solution (0.1%)", "type": "DRUG" }, { "name": "SDP-4 Ophthalmic Solution (1.0%)", "type": "DRUG" }, { "name": "SDP-4 Ophthalmic Solution (3.0%)", "type": "DRUG" }, { "name": "Vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Silk Technologies, Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 305, "start_date": "2019-04-16", "completion_date": "2019-10-11", "has_results": true, "last_update_posted_date": "2022-09-02", "last_synced_at": "2026-10-20T20:45:18.613Z", "location_count": 26, "location_summary": "Azusa, California • Garden Grove, California • Mission Hills, California + 22 more", "locations": [ { "city": "Azusa", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "Mission Hills", "state": "California" }, { "city": "Murrieta", "state": "California" }, { "city": "Newport Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03889886" }, { "nct_id": "NCT01590641", "title": "A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Hepatitis B", "HBV" ], "interventions": [ { "name": "Single Ascending Dose (SAD) Cohorts GS-9620", "type": "DRUG" }, { "name": "Multiple Ascending Dose (MAD) Cohorts", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 49, "start_date": "2012-04", "completion_date": "2013-10", "has_results": false, "last_update_posted_date": "2013-11-14", "last_synced_at": "2026-10-20T20:45:18.613Z", "location_count": 13, "location_summary": "Phoenix, Arizona • Costa Mesa, California • San Diego, California + 10 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Costa Mesa", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "New Orleans", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT01590641" }, { "nct_id": "NCT04159805", "title": "A Study of TAK-079 in People With Generalized Myasthenia Gravis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Myasthenia Gravis" ], "interventions": [ { "name": "TAK-079", "type": "DRUG" }, { "name": "TAK-079 Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 36, "start_date": "2020-01-14", "completion_date": "2022-07-12", "has_results": true, "last_update_posted_date": "2023-06-02", "last_synced_at": "2026-10-20T20:45:18.613Z", "location_count": 27, "location_summary": "Tucson, Arizona • Palo Alto, California • Sacramento, California + 21 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Palo Alto", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT04159805" }, { "nct_id": "NCT06208566", "title": "A Bot-based Self-help Program (WELL)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Well-Being, Psychological" ], "interventions": [ { "name": "Conversational Agent Zenny", "type": "BEHAVIORAL" }, { "name": "Web-based Wellness Resources", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Klagenfurt", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1595, "start_date": "2022-07-04", "completion_date": "2024-03-20", "has_results": false, "last_update_posted_date": "2024-05-16", "last_synced_at": "2026-10-20T20:45:18.613Z", "location_count": 1, "location_summary": "Menlo Park, California", "locations": [ { "city": "Menlo Park", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06208566" } ] }